Cost-effectiveness and cost-utility analysis of Haemate-P versus other von Willebrand disease treatments in Spain
- DOI
- 10.1080/13696998.2025.2474886
- Published
- 2025-03-14
- Container
- Journal of Medical Economics
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/13696998.2025.2474886,
title = {Cost-effectiveness and cost-utility analysis of Haemate-P versus other von Willebrand disease treatments in Spain},
author = {Juan E. Megias-Vericat and Gines Escolar and Michele R. Wilson and Pablo Mendez and Cheryl L. McDade and Laura Vidal Barrientos and Radovan Tomic and Marco Panebianco and Stephan Linden and Songkai Yan},
year = {2025},
journal = {Journal of Medical Economics},
doi = {10.1080/13696998.2025.2474886},
url = {https://doi.org/10.1080/13696998.2025.2474886}
}RIS
TY - JOUR TI - Cost-effectiveness and cost-utility analysis of Haemate-P versus other von Willebrand disease treatments in Spain AU - Juan E. Megias-Vericat AU - Gines Escolar AU - Michele R. Wilson AU - Pablo Mendez AU - Cheryl L. McDade AU - Laura Vidal Barrientos AU - Radovan Tomic AU - Marco Panebianco AU - Stephan Linden AU - Songkai Yan PY - 2025 JO - Journal of Medical Economics DO - 10.1080/13696998.2025.2474886 UR - https://doi.org/10.1080/13696998.2025.2474886 ER -
APA
Megias-Vericat, J. E., Escolar, G., Wilson, M. R., Mendez, P., McDade, C. L., Barrientos, L. V., Tomic, R., Panebianco, M., Linden, S., & Yan, S. (2025). Cost-effectiveness and cost-utility analysis of Haemate-P versus other von Willebrand disease treatments in Spain. Journal of Medical Economics. https://doi.org/10.1080/13696998.2025.2474886
Source records
- crossref · retrieved 2026-11-06T12:17:17.355Z